Fernando de Álvaro

Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial

Marc A. Pohl, Samuel S. Blumenthal, D Cordonnier et al. · Journal of the American Society of Nephrology · 2005 · 373 citations

Functional Longevity of the Human Peritoneum: How Long Is Continuous Peritoneal Dialysis Possible? Results of a Prospective Medium Long-term Study

Rafael Selgas, María José Fernández‐Reyes, Eduardo Bosque et al. · American Journal of Kidney Diseases · 1994 · 234 citations

Functional Longevity, Hemodialysis, Renal Function +10

Target Level for Hemoglobin Correction in Patients With Diabetes and CKD: Primary Results of the Anemia Correction in Diabetes (ACORD) Study

Eberhard Ritz, Maurice Laville, Rudy Bilous et al. · American Journal of Kidney Diseases · 2007 · 149 citations

Diabetes Management, Diabetes, Chronic Kidney Disease +8

C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on Dialysis

Iain C. Macdougall, Rowan G. Walker, Robert Provenzano et al. · Clinical Journal of the American Society of Nephrology · 2008 · 101 citations

Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort study

Alberto Martínez‐Castelao, José Luis Górriz, José Pórtoles et al. · BMC Nephrology · 2011 · 92 citations · Full text